Serotonin and alpha-adrenergic receptors

Serotonin and alpha-adrenergic receptors refer to a combined group of receptor families that are central to neuropharmacology and cardiovascular physiology. Serotonin (5-hydroxytryptamine) receptors comprise seven distinct classes (5-HT1 to 5-HT7), most of which are G protein-coupled receptors (GPCRs) that modulate mood, cognition, and sensory perception [1]. Alpha-adrenergic receptors are GPCRs categorized into alpha-1 and alpha-2 subtypes, which respond to endogenous catecholamines to regulate blood pressure, smooth muscle contraction, and neurotransmitter release [2]. In clinical practice, many drugs are designed to interact with both systems; for instance, atypical antipsychotics like risperidone and clozapine act as antagonists at 5-HT2A and alpha-1 receptors to balance efficacy and side-effect profiles [3]. While these receptors are vital therapeutic targets, the term "Serotonin and alpha-adrenergic receptors" describes a multi-target interaction profile rather than a single protein or gene product [4]. Consequently, this designation is often used in the context of broad-spectrum drugs that treat psychiatric disorders, migraines, and hypertension [5]. The pharmacological modulation of these receptors requires careful titration to avoid adverse effects like orthostatic hypotension or serotonin syndrome [6].

Other names

5-HT and alpha-adrenoceptorsSerotonin and α-adrenergic receptorsSerotonergic and alpha-adrenergic receptor systemsMixed serotonin-adrenergic targets

Competitive antagonism or agonism of various G protein-coupled receptor subtypes (5-HT and alpha-adrenoceptors) to modulate synaptic transmission and vascular tone.